WILLIAMS; Jodi T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for WILLIAMS; Jodi T..The latest application filed is for "alkoxy-substituted pyridinyl derivatives as lpa1 receptor antagonists and their use in the treatment of fibrosis".

Company Profile

0.17.21

WILLIAMS; Jodi T. - Allschwil CH
Williams; Jodi T. - Basel CH
Williams; Jodi T - Basel CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Alkoxy-substituted Pyridinyl Derivatives As Lpa1 Receptor Antagonists And Their Use In The Treatment Of Fibrosis App 20210246116 - BOLLI; Martin ; et al.	2021-08-12
Benzimidazole-proline derivatives Grant 10,329,287 - Boss , et al.	2019-06-25
Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-meth- oxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist Grant 10,023,560 - Boss , et al. July 17, 2	2018-07-17
Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-- yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists Grant 9,914,720 - Boss , et al. March 13, 2	2018-03-13
Use of benzimidazole-proline derivatives Grant 9,914,721 - Boss , et al. March 13, 2	2018-03-13
Crystalline Salt Form Of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-- Yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone As Orexin Receptor Antagonist App 20180002317 - BOSS; Christoph ; et al.	2018-01-04
Benzimidazole-proline Derivatives App 20170305897 - BOSS; Christoph ; et al.	2017-10-26
Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-- yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist Grant 9,790,208 - Boss , et al. October 17, 2	2017-10-17
Use Of Benzimidazole-proline Derivatives App 20170001985 - BOSS; Christoph ; et al.	2017-01-05
Crystalline Form Of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone And Its Use As Orexin Receptor Antagonists App 20160368901 - BOSS; Christoph ; et al.	2016-12-22
Crystalline Salt Form Of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-- Yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone As Orexin Receptor Antagonist App 20160355506 - BOSS; Christoph ; et al.	2016-12-08
Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives Grant 9,493,446 - Bolli , et al. November 15, 2	2016-11-15
Azetidine amide derivatives as orexin receptor antagonists Grant 9,403,813 - Bolli , et al. August 2, 2	2016-08-02
Pyrazole and imidazole derivatives useful as orexin antagonists Grant 9,303,023 - Bolli , et al. April 5, 2	2016-04-05
Azetidine Amide Derivatives As Orexin Receptor Antagonists App 20160024064 - BOLLI; Martin ; et al.	2016-01-28
Proline sulfonamide derivatives as orexin receptor antagonists Grant 9,211,279 - Boss , et al. December 15, 2	2015-12-15
2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists Grant 9,150,566 - Bolli , et al. October 6, 2	2015-10-06
Orexin Receptor Antagonists Which Are [ortho Bi-(hetero-)aryl]-[2-(meta Bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone Derivatives App 20150252032 - Bolli; Martin ; et al.	2015-09-10
Proline Sulfonamide Derivatives As Orexin Receptor Antagonists App 20150246021 - BOSS; Christoph ; et al.	2015-09-03
2-(1,2,3-triazol-2-yl)benzamide And 3-(1,2,3-triazol-2-yl)picolinamide Derivatives As Orexin Receptor Antagonists App 20150158855 - Bolli; Martin ; et al.	2015-06-11
Proline sulfonamide derivatives as orexin receptor antagonists Grant 9,000,029 - Boss , et al. April 7, 2	2015-04-07
Proline Sulfonamide Derivatives As Orexin Receptor Antagonists App 20150057328 - BOSS; Christoph ; et al.	2015-02-26
Proline sulfonamide derivatives as orexin receptor antagonists Grant 8,895,606 - Boss , et al. November 25, 2	2014-11-25
Novel Pyrazole And Imidazole Derivatives Useful As Orexin Antagonists App 20130324579 - Bolli; Martin ; et al.	2013-12-05
Lactam Derivatives Useful As Orexin Receptor Antagonists App 20130237525 - Aissaoui; Hamed ; et al.	2013-09-12
Proline Sulfonamide Derivatives As Orexin Receptor Antagonists App 20130150424 - Boss; Christoph ; et al.	2013-06-13
Oxazolidinone derivatives Grant 8,329,706 - Aissaoui , et al. December 11, 2	2012-12-11
Novel Oxazolidinone Deriviatives App 20120101111 - Aissaoui; Hamed ; et al.	2012-04-26
Thiazolidin-4-one And [1,3]-thiazinan-4-one Compounds As Orexin Receptor Antagonists App 20120088759 - Aissaoui; Hamed ; et al.	2012-04-12
Phenethylamide Derivatives And Their Heterocyclic Analogues App 20110212968 - Aissaoui; Hamed ; et al.	2011-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.